Economists Say "Too Early" to See Significant, Quantifiable CIRM Results
Has the four-year-old, $6-billion, California human embryonic stem cell research effort already paid off?
According to a $50,000 study commissioned by the state stem cell agency, it is "too early to expect to observe significant quantifiable health and economic benefits from CIRM’s funding."
The 31-page report by the Analysis Group of Menlo Park, Ca., whi…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.